These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part II: Management of stage IV disease. Fox MC; Lao CD; Schwartz JL; Frohm ML; Bichakjian CK; Johnson TM J Am Acad Dermatol; 2013 Jan; 68(1):13.e1-13; quiz 26-8. PubMed ID: 23244384 [TBL] [Abstract][Full Text] [Related]
6. The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma. Dummer R; Siano M; Hunger RE; Lindenblatt N; Braun R; Michielin O; Mihic-Probst D; von Moos R; Najafi Y; Guckenberger M; Arnold A Swiss Med Wkly; 2016; 146():w14279. PubMed ID: 26901103 [TBL] [Abstract][Full Text] [Related]
7. [Therapy of malignant melanoma at the stage of distant metastasis]. Garbe C; Eigentler TK Hautarzt; 2004 Feb; 55(2):195-213. PubMed ID: 15043023 [TBL] [Abstract][Full Text] [Related]
8. [Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer]. Négrier S; Fervers B; Bailly C; Beckendorf V; Cupissol D; Doré JF; Dorval T; Garbay JR; Vilmer C Bull Cancer; 2000 Feb; 87(2):173-82. PubMed ID: 10705288 [TBL] [Abstract][Full Text] [Related]
9. Strides in melanoma announced: maximizing value comes next. Tuma RS J Natl Cancer Inst; 2011 Jul; 103(13):997-9. PubMed ID: 21693727 [No Abstract] [Full Text] [Related]
10. BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel. Gonzalez D; Fearfield L; Nathan P; Tanière P; Wallace A; Brown E; Harwood C; Marsden J; Whittaker S Br J Dermatol; 2013 Apr; 168(4):700-7. PubMed ID: 23360189 [TBL] [Abstract][Full Text] [Related]
11. [Systemic treatment of melanoma brain metastases]. Le Rhun É; Mateus C; Mortier L; Dhermain F; Guillot B; Grob JJ; Lebbe C; Thomas M; Jouary T; Leccia MT; Robert C Cancer Radiother; 2015 Feb; 19(1):48-54. PubMed ID: 25656856 [TBL] [Abstract][Full Text] [Related]
12. [Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)]. Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ; ; ; ; ; ; ; Bull Cancer; 2006 Apr; 93(4):371-84. PubMed ID: 16714227 [TBL] [Abstract][Full Text] [Related]
13. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma. Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815 [No Abstract] [Full Text] [Related]
14. Systemic treatments for advanced cutaneous melanoma. Anderson CM; Buzaid AC; Legha SS Oncology (Williston Park); 1995 Nov; 9(11):1149-58; discussion 1163-4, 1167-8. PubMed ID: 8703684 [TBL] [Abstract][Full Text] [Related]
15. Molecularly targeted therapies for melanoma. Liu LS; Colegio OR Int J Dermatol; 2013 May; 52(5):523-30. PubMed ID: 23590367 [TBL] [Abstract][Full Text] [Related]
16. Melanoma brain metastasis: overview of current management and emerging targeted therapies. Fonkem E; Uhlmann EJ; Floyd SR; Mahadevan A; Kasper E; Eton O; Wong ET Expert Rev Neurother; 2012 Oct; 12(10):1207-15. PubMed ID: 23082737 [TBL] [Abstract][Full Text] [Related]